Navigation Links
CIHR news: health research touching lives
Date:5/7/2008

This release is available in French.

Ottawa (May 7, 2008) The Honourable Tony Clement, Minister of Health announced today funding from the Canadian Institutes of Health Research (CIHR) for 764 health research projects across Canada, totalling over $298 million. Minister Clement was joined by Dr. Patrick McGrath, a member of CIHRs Governing Council, Dr. Po-Yin Cheung, a neonatologist and CIHR-funded researcher from the University of Alberta, and Luis and Oksana Delgado from Edmonton, whose 22 month old son Adrian received medical care from Dr. Cheung when he suffered low oxygen and its complications at birth. Using state-of-the-art resources and knowledge from his research, Dr. Cheung and his health-care team helped Adrian make a full recovery.

The Government of Canada is committed to investing in knowledge, science and innovation, said Minister Clement. In Budget 2008, we increased CIHRs budget by $34 million and we made a number of other strategic investments designed to further strengthen Canadas research capacity. The research being supported with the funding announced today will help us address important health issues affecting Canadians, such as cancer, heart disease and HIV/AIDS. Im very pleased the Delgado family could be with us today. Their story provides a wonderful example of how health research is helping Canadians.

With funding from CIHR, Dr. Cheung has been investigating ways to reduce damage to the heart from resuscitating oxygen-deprived newborns. He is one of the recipients of the funding announced today.

This funding from CIHR is very important because it will allow me to continue my work discovering novel ways to improve the recovery of babies born with oxygen-deprivation, said Dr. Cheung.

The 764 research projects funded underwent a rigorous peer-review process before being approved and exemplify CIHR's comprehensive, problem-based approach to funding excellence in health research. The funded research projects will be carried out over periods of one to five years. Here are some additional examples of the projects funded:

  • Deborah Money (University of British Columbia) will evaluate how the HPV vaccine works in HIV-positive women and whether it can help protect women against HPV and its related health issues.
  • Dr. Janet Smylie (St. Michaels Hospital, University of Toronto) will work with First Nations and Mtis communities to make parenting and child health programs more responsive to the needs of First Nations and Mtis children and their families.
  • Dr. Sylvain Martel (cole polytechnique de Montral, Universit de Montral) will use an MRI scanner to deliver microbeads with anti-cancer drugs directly into liver tumours.

CIHR funds the best ideas and the brightest minds, and the projects announced today are no exception, said Dr. McGrath. CIHR is proud to be supporting the work of outstanding researchers like Dr. Cheung. The talented researchers leading the projects announced today will advance knowledge in many important areas, and provide a stimulating environment for young Canadians training for careers in health research.


'/>"/>

Contact: David Coulombe
mediarelations@cihr.gc.ca
613-941-4563
Canadian Institutes of Health Research
Source:Eurekalert

Related medicine news :

1. CIHR news: U of S scientists find plant gene that affects stress resistance
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. UCLA researchers identify markers that may predict diabetes in still-healthy people
4. Air pollution linked to cardiovascular risk indices in healthy young adults
5. More proof needed of safety and quality of electronic personal health records
6. Health care incentive model offers collaborative approach
7. Loneliness is bad for your health
8. Mailman School of Public Health study examines link between racial discrimination and substance use
9. Green Tea May Brew Up Healthier Skin
10. For Health Info, Women Often Turn to the Web
11. Record Number of Americans Lack Health Insurance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
(Date:4/28/2017)... Manhattan New york (PRWEB) , ... April 28, ... ... is pleased to announce that Aditya Patel M.D. has joined the revolutionary endoscopic ... fellowship training and board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt ...
(Date:4/28/2017)... Edinburg, Texas (PRWEB) , ... April 28, 2017 , ... ... a plaque in recently to the labor and delivery team at Women’s Hospital at ... generous mothers who give birth at the hospital and decide to donate. , ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and elimination ... safety and minimize the cost of development. In this webinar, sponsored by Molecular ... lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , In ...
(Date:4/28/2017)... ... 28, 2017 , ... Bill Howe started his sewer and drain company in ... Howe joined the team, the Bill Howe brand was born and they began cultivating ... giving back to the San Diego community in which they worked, lived and were ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Texas , April 20, 2017  Vivify Health, ... mobile devices, has been awarded a very significant patent ... via EMRs to continual care via digital health.  This ... key intellectual property and further secures Vivify,s position as ... launched in 2009, was the first company to apply ...
(Date:4/20/2017)... WOONSOCKET, R.I. , April 20, 2017 /PRNewswire/ ... (NYSE: CVS), today unveiled a new store design ... new assortment of healthier food, health-focused products and ... the store to help customers discover new offerings. ... represent the next evolution of the customer experience ...
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
Breaking Medicine Technology: